Finance News Network

Interviews

Investing in essential services property for above average dividend yield

02 Mar 2023 - Scott Kelly, RAM CEO Australia, provides an introduction to the RAM Essential Services Property Fund (ASX:REP), discussing geographical spread, yield, investment stra…

Immutep (ASX:IMM) delivering strong data in first-line non-small cell lung cancer

01 Mar 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses data from SITC, the strategy to take Efti to market and milestones for 2023.

BluGlass (ASX:BLG) secures first customer orders for gallium nitride lasers

21 Feb 2023 - BluGlass Limited (ASX:BLG) President Jim Haden provides an update on the company, discussing the launch of the company's first suite of laser products, integration of…

Etherstack (ASX:ESK) delivers 51% NPAT growth

20 Feb 2023 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon discusses the company's 2022 financial highlights and outlook for 2023.

Market update with Shaw and Partners, February 2023

17 Feb 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses financial conditions, the outlook for growth, central bank monetary policy, and what this means for …

Radiopharm Theranostics (ASX:RAD) eyes NASDAQ listing

17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an upd…

Trigg Minerals (ASX:TMG) trials innovative new process for potash (SOP) production

15 Feb 2023 - The bench-scale test work indicates the alternative process has the potential to improve processing reliability and feed-salt quality, positively impact costs and acc…

How Splitit's (ASX:SPT) business model differs from BNPL companies

13 Feb 2023 - Splitit Limited (ASX:SPT) CEO Nandan Sheth discusses the buy now, pay later sector, and Splitit's business model partnerships.

What's the outlook for the listed property sector?

09 Feb 2023 - Sequoia Asset Management Investment Manager Winston Sammut discusses property investment strategy, the impacts of COVID and work from home, shopping malls, industrial…

RareX (ASX:REE) developing a top-three rare earths project in WA

14 Dec 2022 - RareX Limited (ASX:REE) Managing Director Jeremy Robinson discusses progress at the Cummins Range rare earths project and a potential resource upgrade.

Rural Funds Group (ASX:RFF) FY22 Financial Results Summary

30 November 2022 - James Powell, the General Manager - Investor Relations, Corporate Affairs and Sustainability of the Rural Funds Group Limited (ASX:RFF), presents on the group's …

Immutep (ASX:IMM) discusses a transformative year for LAG-3 therapies

28 Nov 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the LAG-3 landscape, the company's portfolio of therapies, encouraging data from the 2022 SI…

BluGlass demonstrates feasible reliability of laser diodes

25 Nov 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses achieving a key reliability milestone for the company's laser diodes.

The alternative to lithium

23 Nov 2022 - Altech Chemicals Limited (ASX:ATC) CFO Martin Stein discusses the recent joint venture with Fraunhofer IKTS and the CERENERGY solid state sodium alumina battery.

Radiopharm Theranostics (ASX:RAD) to commence NSCLC trial in Australia

22 Nov 2022 - Radiopharm Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapie…

Genetic Signatures (ASX:GSS) - detecting infectious diseases in high-throughput lab workflows

17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.

Arovella Therapeutics (ASX:ALA) - tackling blood cancers and solid tumours

15 Nov 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Dr Michael Baker provides an update on the company.

OncoSil Medical (ASX:OSL) - targeted therapy for pancreatic cancer

15 Nov 2022 - OncoSil Medical Limited (ASX:OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy…

K2fly (ASX:K2F) - providing ESG solutions for top 50 mining companies

11 Nov 2022 - K2fly Limited (ASX:K2F) CEO Nic Pollock discusses K2F's progress and milestones over the past year.

Chimeric Therapeutics (ASX:CHM) enters research agreement to advance cell therapy portfolio

04 Nov 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses the company's new agreement with Case Western Reserve University.

Antisense Therapeutics (ASX:ANP) discusses upcoming AGM resolutions and new management appointment

03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief Commercial Officer, Dr Anthony Filippis, discuss Antisense's progress, attractin…

Novonix (ASX:NVX) receives US$150m grant for EV battery production

02 Nov 2022 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses news following the company's AGM, including the appointment of new directors and the expansion of the company's…

Market update with Shaw and Partners, October 2022

31 Oct 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market outlook, giving general advice on investment implications.

icetana (ASX:ICE) discusses Macnica deal and new product launch

27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.

Immutep (ASX:IMM) receives fast track designation from FDA

12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the compan…

Prior Page Next Page